Cargando…
Gene expression profiling of cutaneous wound healing
BACKGROUND: Although the sequence of events leading to wound repair has been described at the cellular and, to a limited extent, at the protein level this process has yet to be fully elucidated. Genome wide transcriptional analysis tools promise to further define the global picture of this complex p...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1804259/ https://www.ncbi.nlm.nih.gov/pubmed/17313672 http://dx.doi.org/10.1186/1479-5876-5-11 |
_version_ | 1782132443025768448 |
---|---|
author | Deonarine, Kavita Panelli, Monica C Stashower, Mitchell E Jin, Ping Smith, Kina Slade, Herbert B Norwood, Christopher Wang, Ena Marincola, Francesco M Stroncek, David F |
author_facet | Deonarine, Kavita Panelli, Monica C Stashower, Mitchell E Jin, Ping Smith, Kina Slade, Herbert B Norwood, Christopher Wang, Ena Marincola, Francesco M Stroncek, David F |
author_sort | Deonarine, Kavita |
collection | PubMed |
description | BACKGROUND: Although the sequence of events leading to wound repair has been described at the cellular and, to a limited extent, at the protein level this process has yet to be fully elucidated. Genome wide transcriptional analysis tools promise to further define the global picture of this complex progression of events. STUDY DESIGN: This study was part of a placebo-controlled double-blind clinical trial in which basal cell carcinomas were treated topically with an immunomodifier – toll-like receptor 7 agonist: imiquimod. The fourteen patients with basal cell carcinoma in the placebo arm of the trial received placebo treatment consisting solely of vehicle cream. A skin punch biopsy was obtained immediately before treatment and at the end of the placebo treatment (after 2, 4 or 8 days). 17.5K cDNA microarrays were utilized to profile the biopsy material. RESULTS: Four gene signatures whose expression changed relative to baseline (before wound induction by the pre-treatment biopsy) were identified. The largest group was comprised predominantly of inflammatory genes whose expression was increased throughout the study. Two additional signatures were observed which included preferentially pro-inflammatory genes in the early post-treatment biopsies (2 days after pre-treatment biopsies) and repair and angiogenesis genes in the later (4 to 8 days) biopsies. The fourth and smallest set of genes was down-regulated throughout the study. Early in wound healing the expression of markers of both M1 and M2 macrophages were increased, but later M2 markers predominated. CONCLUSION: The initial response to a cutaneous wound induces powerful transcriptional activation of pro-inflammatory stimuli which may alert the host defense. Subsequently and in the absence of infection, inflammation subsides and it is replaced by angiogenesis and remodeling. Understanding this transition which may be driven by a change from a mixed macrophage population to predominately M2 macrophages, may help the interpretation of the cellular and molecular events occurring in the microenvironment of serially biopsied tissues. |
format | Text |
id | pubmed-1804259 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2007 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-18042592007-02-24 Gene expression profiling of cutaneous wound healing Deonarine, Kavita Panelli, Monica C Stashower, Mitchell E Jin, Ping Smith, Kina Slade, Herbert B Norwood, Christopher Wang, Ena Marincola, Francesco M Stroncek, David F J Transl Med Research BACKGROUND: Although the sequence of events leading to wound repair has been described at the cellular and, to a limited extent, at the protein level this process has yet to be fully elucidated. Genome wide transcriptional analysis tools promise to further define the global picture of this complex progression of events. STUDY DESIGN: This study was part of a placebo-controlled double-blind clinical trial in which basal cell carcinomas were treated topically with an immunomodifier – toll-like receptor 7 agonist: imiquimod. The fourteen patients with basal cell carcinoma in the placebo arm of the trial received placebo treatment consisting solely of vehicle cream. A skin punch biopsy was obtained immediately before treatment and at the end of the placebo treatment (after 2, 4 or 8 days). 17.5K cDNA microarrays were utilized to profile the biopsy material. RESULTS: Four gene signatures whose expression changed relative to baseline (before wound induction by the pre-treatment biopsy) were identified. The largest group was comprised predominantly of inflammatory genes whose expression was increased throughout the study. Two additional signatures were observed which included preferentially pro-inflammatory genes in the early post-treatment biopsies (2 days after pre-treatment biopsies) and repair and angiogenesis genes in the later (4 to 8 days) biopsies. The fourth and smallest set of genes was down-regulated throughout the study. Early in wound healing the expression of markers of both M1 and M2 macrophages were increased, but later M2 markers predominated. CONCLUSION: The initial response to a cutaneous wound induces powerful transcriptional activation of pro-inflammatory stimuli which may alert the host defense. Subsequently and in the absence of infection, inflammation subsides and it is replaced by angiogenesis and remodeling. Understanding this transition which may be driven by a change from a mixed macrophage population to predominately M2 macrophages, may help the interpretation of the cellular and molecular events occurring in the microenvironment of serially biopsied tissues. BioMed Central 2007-02-21 /pmc/articles/PMC1804259/ /pubmed/17313672 http://dx.doi.org/10.1186/1479-5876-5-11 Text en Copyright © 2007 Deonarine et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Deonarine, Kavita Panelli, Monica C Stashower, Mitchell E Jin, Ping Smith, Kina Slade, Herbert B Norwood, Christopher Wang, Ena Marincola, Francesco M Stroncek, David F Gene expression profiling of cutaneous wound healing |
title | Gene expression profiling of cutaneous wound healing |
title_full | Gene expression profiling of cutaneous wound healing |
title_fullStr | Gene expression profiling of cutaneous wound healing |
title_full_unstemmed | Gene expression profiling of cutaneous wound healing |
title_short | Gene expression profiling of cutaneous wound healing |
title_sort | gene expression profiling of cutaneous wound healing |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1804259/ https://www.ncbi.nlm.nih.gov/pubmed/17313672 http://dx.doi.org/10.1186/1479-5876-5-11 |
work_keys_str_mv | AT deonarinekavita geneexpressionprofilingofcutaneouswoundhealing AT panellimonicac geneexpressionprofilingofcutaneouswoundhealing AT stashowermitchelle geneexpressionprofilingofcutaneouswoundhealing AT jinping geneexpressionprofilingofcutaneouswoundhealing AT smithkina geneexpressionprofilingofcutaneouswoundhealing AT sladeherbertb geneexpressionprofilingofcutaneouswoundhealing AT norwoodchristopher geneexpressionprofilingofcutaneouswoundhealing AT wangena geneexpressionprofilingofcutaneouswoundhealing AT marincolafrancescom geneexpressionprofilingofcutaneouswoundhealing AT stroncekdavidf geneexpressionprofilingofcutaneouswoundhealing |